312 filings
Page 3 of 16
D
p47e6k
8 Jun 22
$5.06M in equity / options / securities to be acquired, sold $5.06M, 25 investors
11:17am
8-K
9h2sxrcp 1p
16 May 22
Biostage Reports Q1 2022 Financial Results and Corporate Highlights
4:31pm
8-K
vkx8 6nd30j
13 May 22
Biostage Announces $5.1 Million Financing to Advance Clinical Trial
8:45am
DEFA14A
51rw9pm
2 May 22
Additional proxy soliciting materials
4:44pm
8-K
6wvdb0q6
28 Apr 22
Entry into a Material Definitive Agreement
4:31pm
8-K
zdw6q qyx
1 Apr 22
Biostage Reports Fourth Quarter and Fiscal Year 2021 Financial Results
7:45am
8-K
92xitt
3 Feb 22
Other Events
4:06pm
8-K
c0xnnseont
27 Jan 22
Other Events
8:01am
8-K
uy5rh 8ham854p
6 Dec 21
Regulation FD Disclosure
8:30am
8-K
xhsex09m7 gy05
30 Nov 21
Entry into a Material Definitive Agreement
8:45am
8-K
phgxvf i4wpf
15 Nov 21
Biostage Reports Q3 2021 Financial Results
12:00am
8-K
vftlb8 ycai
24 Sep 21
Other Events
9:10am
D/A
udr4ay8d94xnp9
10 Sep 21
$3M in equity / options / securities to be acquired, sold $2.6M, 2 investors
1:15pm
8-K
xknpys
8 Sep 21
Biostageā¢ Appoints Jerry He to Board of Directors and Completes Private Placement of $2.6 Million to Continue Its Clinical Transition
9:09am
8-K
cwpu5jbtl6h
13 Aug 21
Biostage Reports Q2 2021 Financial Results
4:16pm